Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models

Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cogniti...

Full description

Saved in:
Bibliographic Details
Published inBasic & clinical pharmacology & toxicology Vol. 134; no. 6; pp. 770 - 777
Main Authors Moreira Vasconcelos, Carlos Franciney, Neugebauer, Agnieszka Zofia, Basto Souza, Ricardo
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases.
Bibliography:Died February 6, 2024.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1742-7835
1742-7843
DOI:10.1111/bcpt.14006